HIGHLIGHTS
- who: Sahar Tahaghoghi-Hajghorbani from the DepartmentMazandaran University have published the research: Targeting the tumor microenvironment by liposomal Epacadostat in combination with liposomal gp100 vaccine, in the Journal: Scientific Reports Scientific Reports
- what: The aim of this study was to compare a tumor targetted therapy via liposomes in combination with a cancer vaccine with a nanoliposomal form of EPA and to improve the efficacy of the drug in a mice melanoma model. In the first step of the study , the authors evaluated IDO expression in the cell lines. The reduced mRNA expression of the IDO . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.